Trade Mark Journal No.2025/034 22 August 2025
WO0000001868565 (9,35,36,41,44)
Office of origin: United States of America
Date of International Registration:13 March 2025
Date of designation in the UK:
13 March 2025
International priority date claimed: 24 September 2024
(United States of America)
(98766547)
- Class 9
- Downloadable mobile applications for providing a patient assistance program for providing prescription drugs at reduced cost, patient medication care management, and medication adherence.
- Class 35
- Business administration of a patient assistance program for providing prescription drugs at reduced cost.
- Class 36
- Financial administration of a patient assistance program for providing prescription drugs at reduced cost; facilitating and coordinating insurance authorization for prescriptions between and among patients, doctors, care-givers, and insurance, and communicating with patients regarding prescription cost and insurance coverage of prescription drugs; providing information regarding insurance coverage and reimbursement for prescription drugs.
- Class 41
- Educational services, namely, conducting educational programs in the fields of diseases, disorders, or conditions of the nervous system, and treatment and patient support options for these conditions.
- Class 44
- Charitable services, namely, a patient assistance program for providing prescription drugs at reduced cost or free of charge; patient medication care management and medication adherence services, namely, communicating with patients regarding their medications, adherence to medication regimens, medication side-effects, allergic sensitivity, drug interactions, and other issues related to medication tolerance, alternate medication brands or generics, dosage, or manner of taking medications.
IntraBio Inc.
Representative: Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C., 1101 K Street, N.W.,, 10th Floor, Washington DC 20005, UNITED STATES OF AMERICA